Gunnar Wiedenfels sells Series A shares (WBD) totaling $24.6M in recent filings

Rhea-AI Filing Summary

Warner Bros. Discovery insider filings show proposed and recent dispositions of Series A shares by Gunnar Wiedenfels. The filing lists prior sales of 242,994 Series A shares on 12/10/2025 for $7,168,323.00 and 617,580 Series A shares on 03/03/2026 for $17,448,357.18. The form also lists planned transfers tied to restricted stock vesting and option-related exercises dated 03/03/2026 and 03/04/2026.

Insights

Corporate Governance Analyst

Insider sales reported by the CEO/insider were large in absolute dollar terms but routine in form.

The filing records two recent dispositions: 242,994 Series A shares on 12/10/2025 for $7,168,323.00 and 617,580 Series A shares on 03/03/2026 for $17,448,357.18. These entries appear as reported sales and planned transfers tied to vesting and option exercises.

Cash‑flow treatment and any trading method are not detailed in the excerpt; subsequent filings or transaction footnotes would clarify whether sales were open‑market, block trades, or for tax withholding.

FAQ

What did the WBD Form 144 report for Gunnar Wiedenfels?

The Form 144 reports disclosed sales of Series A shares by Gunnar Wiedenfels on specific dates. It lists sales of 242,994 shares on 12/10/2025 for $7,168,323.00 and 617,580 shares on 03/03/2026 for $17,448,357.18.

Does the filing show any planned equity transfers for WBD insiders?

Yes. The excerpt lists planned transfers tied to vesting and option events dated 03/03/2026 and 03/04/2026, including restricted stock vesting of 28,190 shares and option‑related entries of 91,418; 131,127; and 123,588 shares.

Are proceeds from the reported sales disclosed in the filing?

Yes. The filing shows gross proceeds for the two reported sales: $7,168,323.00 for the 242,994‑share sale and $17,448,357.18 for the 617,580‑share sale, each tied to the dates shown in the excerpt.

Does the excerpt state how the shares were sold (method or broker)?

The provided excerpt does not detail sale methods. It names a broker address and lists transactions, but it does not specify whether sales were open‑market, block trades, or for tax withholding in this excerpt.

Is there an indication these are issuer grants or secondary sales?

The filing differentiates items: some rows show restricted stock vesting and options granted (issuer actions), while the reported sales rows list actual dispositions by Gunnar Wiedenfels, indicating secondary sales in the records shown.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 04:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001694392
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Warner Bros. Discovery, Inc.
SEC File Number	001-34177
Address of Issuer	230 PARK AVENUE SOUTH NEW YORK NEW YORK 10003
Phone	212-548-5555
Name of Person for Whose Account the Securities are To Be Sold	Wiedenfels Gunnar
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Series A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	374323	10498860.82	2479929515	03/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Series A	03/03/2026	Restricted Stock Vesting	Issuer			28190	03/03/2026	Compensation
Series A	03/04/2026	Option Granted - 03/01/2023	Issuer			91418	03/04/2026	Cash
Series A	03/04/2026	Option Granted - 03/01/2024	Issuer			131127	03/04/2026	Cash
Series A	03/04/2026	Option Granted - 03/03/2025	Issuer			123588	03/04/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Gunnar Wiedenfels 230 Park Avenue South New York NY 10003	Series A	12/10/2025	242994	7168323.00
Gunnar Wiedenfels 230 Park Avenue South New York NY 10003	Series A	03/03/2026	617580	17448357.18

144: Remarks and Signature

Remarks
Date of Notice	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Gunnar Wiedenfels
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)